Therapies targeting the biological mechanisms of pre-leukemic MDS may improve patient outcomes, according to data presented at the SOHO 2023 annual meeting by Juan Jose Rodriguez-Sevilla, PhD.
Therapies targeting the biological mechanisms of pre-leukemic MDS may improve patient outcomes, according to data presented at the SOHO 2023 annual meeting by Juan Jose Rodriguez-Sevilla, PhD.
Therapies targeting the...